课题基金 / 基金详情

Expression and prognostic significance of cadherin and detection system of ciculating cancer cells in renal cell carcinoma

Expression and prognostic significance of cadherin and detection system of ciculating cancer cells in renal cell carcinoma
肾细胞癌中钙粘蛋白的表达及预后意义及循环癌细胞检测系统
批准号:
10671457
负责人:
SHIMAZUI Toru
金额:
$0.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

SHIMAZUI Toru的其他基金

相似基金

相关文献

中文摘要
翻译
大多数肾细胞癌(RCC)不表达E-钙粘蛋白和肾近端小管上皮细胞。相反,肾细胞癌在体外频繁表达钙粘蛋白-6和N-钙粘蛋白以及与其生物学行为相关的钙粘蛋白-6。因此,我们使用抗人钙粘蛋白-6的单抗来研究钙粘蛋白-6是否是肾癌中有用的分子标志物。43例肾癌患者中有24例存在钙粘蛋白-6的异常表达,其预后明显较差,尤其是E-钙粘蛋白缺失者。由于肾细胞癌转移灶中钙粘蛋白-6和N-钙粘蛋白的表达一直保持不变,因此我们进一步研究了利用RT-PCR技术在循环血中检测到这些特异性钙粘蛋白的表达。然而,在健康志愿者的外周血中,用巢式RT-PCR系统频繁地检测到N-钙粘素的mRNA。在15例转移性肾癌患者中有11例检测到钙粘蛋白-6基因的表达,而在12例肾癌转移性肿瘤患者中有6例检测到钙粘蛋白-6基因的表达。考虑到需要进行定量分析以稳定该方法的敏感性,因此我们用定量RT-PCR法重新分析了外周血中钙粘蛋白-6基因的表达水平。在检测了健康志愿者外周血中钙粘蛋白-6基因的表达水平后,在13例转移性肾细胞癌患者中有9例检测到了钙粘蛋白-6基因的表达。钙粘附素-6的定量RT-PCR可能是检测肾癌患者循环血中肾细胞癌细胞的有用工具。
英文摘要
Most renal cell carcinomas (RCCs) do not express E-cadheirn as well as renal proximal tubular epithelium. Instead of this, RCC frequently expresses cadheirn-6 and N-cadherin and cadherin-6 correlated with biological behavior of RCC cell line in vitro. Thus, we investegated whether cadherin-6 was a useful molecular marker in RCC using monoclonal antibody against human cadherin-6. Abnormal expression of cadherin-6 was observed in 24 of 43 RCC patients and those patients siginificantly had a poorer prognosis, specially in the patietns with E-cadherin-absent RCC.Since expression of cadherin-6 and N-cadherin was preserved in the metastatic site of RCC, we next studied that RCC cells could be detected in circulating blood using RT-PCR for these specific cadherin mRNA.Both of cadheirn-6 and N-cadherin were expressed in RCC cell line, normal kidney and RCC specimens. However, in the peripheral blood from healthy volunteers N-cadherin mRNA was frequently detected using nested RT-PCR system. Cadherin-6 mRNA was observed in 11 out of 15 patietns with metastasis, whereas in 6 out of 12 patients withour metastasis of RCC.It has been considered that quantitative nanalyses should be needed to stabilize the sensitivity of this PCR assay, so that we reanalysed the expression level of cadherin-6 mRNA in peripheral blood using quantitative RT-PCR.After cut off level of cadhiern-6 mRNA was determined in healthy volunteers, cadherin-6 mRNA was detected in 9 out of 13 patietns with metastatic RCC.In contrast, in 36 RCC patients withour metastasis, cadheirn-6 mRNA was detected in 13 patietns before nephrectomy and it decreased into normal range in 6 patients after surgery. Quantitative RT-PCR for Cadherin-6 might be a useful tool to detect RCC cells in ciculating blood in RCC patients.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Shimazui,T.et al.: "Expression of cadherin-6 as a novel digunostic tool to predict prognosis of pations with E-cadherin-absent cell carcinoma" Cliuical Caucer Researdr. 4. 2419-2424 (1998)
Shimazui,T.et al.:“钙粘蛋白 6 的表达作为一种新的诊断工具来预测 E-钙粘蛋白缺失细胞癌的预后”Cliuical Caucer Researdr。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimazui, T.et al.: "Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients Loith E-cadherin-absent renal cell carcinoma"Clin Cancer Res. 4. 2419-2424 (1998)
Shimzui, T.et al.:“钙粘蛋白 6 的表达作为预测 Loith E-钙粘蛋白缺失肾细胞癌患者预后的新型诊断工具”Clin Cancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimazui T, Oosterwijk E, Akaza H, Bringuier P, Ruijter E, van Berkel H, Wakka JO, van Bokhoven A: "Debruyne FM, Schalken JA. : Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinom
Shimazui T、Oosterwijk E、Akaza H、Bringuier P、Ruijter E、van Berkel H、Wakka JO、van Bokhoven A:“Debruyne FM、Schalken JA。:cadherin-6 的表达作为预测患者预后的新型诊断工具
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
New strategy of intravesical in stillation using anti-cancer peptide for bladder tumor
  • 批准号:
    21592031
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    SHIMAZUI Toru
  • 依托单位:
Prediction of in vitro response to interferon-alpha and acquisition of its susceptibility by gene and peptide transduction system
  • 批准号:
    18591739
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.53万
  • 财政年份:
    2006
  • 负责人:
    SHIMAZUI Toru
  • 依托单位:
Gene expression profiling in association with interferon-alpha-sensitivity for the personalized treatment of renal cell carcinoma
  • 批准号:
    15591669
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2003
  • 负责人:
    SHIMAZUI Toru
  • 依托单位:
Alteration of expression profiling related the biological characteristics of renal cell carcinoma using cDNA microarray.
  • 批准号:
    13671633
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.43万
  • 财政年份:
    2001
  • 负责人:
    SHIMAZUI Toru
  • 依托单位:
国内基金
海外基金
基于脑类器官模型探究Cadherin在SYNGAP1突变所致神经发育异常中的修复作用及机制
  • 批准号:
    2026JJ60298
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐甜甜
  • 依托单位:
基于NF-κB/IL-1β与Snail/E-cadherin细胞信号通讯技术探讨胰腺炎癌转化分子机制研究
Ca2+/Cadherin复合体在毛干附着及其响应压力型脱发的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    李洁华
  • 依托单位:
微环境中N-cadherin和E-cadherin互作控制干细胞自我更新的机制 研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    屠仁军
  • 依托单位: